Skip to main content
. 2014 Mar 4;9(5):1597–1605. doi: 10.3892/mmr.2014.2003

Table I.

Immunohistochemical and clinical characteristics of nine patients with esophageal carcinoma used for sequencing alternative polyadenylation sites and quantitative polymerase chain reaction analysis.

Case # Age/Gender Neu EGFR TOPII P53 Ki67 (%) PCNA P21 GST-π c-myc P27
0a 52/M + 5 ++ + + ++
1b 66/M 5 + +
2b 66/M ++ + + 20 ++ + ++ +
3b 65/M ++ ++ 5 ++ +
4b 74/F ++ ++ +
6b 59/F + + 5 ++ +
7b 68/M + + + 20 + +
14b 72/F ++ 5 ++ + +
16b 56/M + 30 ++ + +
a

Samples used for sequencing;

b

Samples used for qPCR analysis.

M, male; F, female; EGFR, epidermal growth factor receptor; Neu, neuro/glioblastoma derived oncogene homolog; TOPII, DNA topoisomerase II; PCNA, proliferating cell nuclear antigen; GST, glutathione S-transferase.